Alto Neuroscience Wants to Revolutionize Mental Health Treatment

Fresh of its IPO at the NYSE, CEO of Alto Neuroscience Dr. Amit Etkin discusses how the company wants to innovate psychiatric medicine.
More Videos
Load More